Back
Ocuphire Pharma Stock Price Chart
Sponsored
OCUP
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
OCUP
Ocuphire Pharma
Last Price:
1.35
Seasonality Move:
-20.18%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager- The current trend is relatively stagnant and OCUP is experiencing selling pressure, which indicates risk of future bearish movement.
Ocuphire Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.27 | Buy |
20-day SMA: | 1.27 | Buy |
50-day SMA: | 1.57 | Sell |
200-day SMA: | 2.04 | Sell |
8-day EMA: | 1.28 | Buy |
20-day EMA: | 1.31 | Sell |
50-day EMA: | 1.46 | Sell |
200-day EMA: | 2.03 | Sell |
Ocuphire Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 45.9 | Sell |
Chaikin Money Flow: | -46105 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.22 - 1.32) | Buy |
Bollinger Bands (100): | (1.38 - 1.88) | Sell |
Ocuphire Pharma Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ocuphire Pharma Stock
Is Ocuphire Pharma Stock a Buy?
- Ocuphire Pharma share price is 1.31 while OCUP 8-day simple moving average is 1.27, which is a Buy signal.
- The stock price of OCUP is 1.31 while Ocuphire Pharma 20-day SMA is 1.27, which makes it a Buy.
- Ocuphire Pharma 50-day simple moving average is 1.57 while OCUP share price is 1.31, making it a Sell technically.
- OCUP stock price is 1.31 and Ocuphire Pharma 200-day simple moving average is 2.04, creating a Sell signal.
OCUP Technical Analysis vs Fundamental Analysis
Sell
33
Ocuphire Pharma (OCUP)
is a Sell
Is Ocuphire Pharma a Buy or a Sell?
-
Ocuphire Pharma stock is rated a Sell
The current Ocuphire Pharma [OCUP] share price is $1.31. The Score for OCUP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Ocuphire Pharma Stock Info
Market Cap:
34.32M
Price in USD:
1.31
Share Volume:
76.84K
Ocuphire Pharma 52-Week Range
52-Week High:
4.50
52-Week Low:
1.15
Sell
33
Ocuphire Pharma (OCUP)
is a Sell
Ocuphire Pharma Share Price Forecast
-
What is the Ocuphire Pharma stock price today?
The Ocuphire Pharma stock price is 1.31 USD today. -
Will OCUP stock go up or go down?
Ocuphire Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is Ocuphire Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ocuphire Pharma is overvalued.
Is Ocuphire Pharma Stock a Buy?
- Ocuphire Pharma share price is 1.31 while OCUP 8-day exponential moving average is 1.28, which is a Buy signal.
- The stock price of OCUP is 1.31 while Ocuphire Pharma 20-day EMA is 1.31, which makes it a Sell.
- Ocuphire Pharma 50-day exponential moving average is 1.46 while OCUP share price is 1.31, making it a Sell technically.
- OCUP stock price is 1.31 and Ocuphire Pharma 200-day simple moving average is 2.03, creating a Sell signal.
Fundamental Analysis of Ocuphire Pharma
Is Ocuphire Pharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.24 per share, and an increase next year of $0.78 per share.
Technical Analysis of Ocuphire Pharma
Should I short Ocuphire Pharma stock?
- OCUP Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Ocuphire Pharma is a Sell
- Ocuphire Pharma Relative Strength Index (RSI) is 45.9, which suggest Ocuphire Pharma is oversold
- The Bollinger Bands (25) for Ocuphire Pharma is (1.22 - 1.32), which suggest Ocuphire Pharma is a Sell
- The Bollinger Bands (100) for Ocuphire Pharma is (1.38 - 1.88), which suggest Ocuphire Pharma is a Sell
* Ocuphire Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.